SCS is contributing to this exciting new field by providing tools, reagents and cells for the discovery of regenerative medicines or identification of cells for transplantation.
Our reagents and technologies facilitate discovery of medicines that work on the biology of the stem cells rather than on the physiology of the products of the stem cells.
As pharmas set up their regenerative medicine biotec ventures, many are focusing on screening existing medicines and discovering new ones which will intrinsically stimulate repair or reverse the damage in tissues, in a controlled way, as well as identifying cells that are safe for transplantation.
SCS’s knowledge of stem cells and our reagents place us is an unique position to provide stem cell assays to discover new medicines which will stimulate more stem cells in formation or stimulate those stem cells to make new, better and more neurons in volume.

